AU3350097A - Immunocontraceptive methods and peptide or polypeptides for use in these methods - Google Patents
Immunocontraceptive methods and peptide or polypeptides for use in these methodsInfo
- Publication number
- AU3350097A AU3350097A AU33500/97A AU3350097A AU3350097A AU 3350097 A AU3350097 A AU 3350097A AU 33500/97 A AU33500/97 A AU 33500/97A AU 3350097 A AU3350097 A AU 3350097A AU 3350097 A AU3350097 A AU 3350097A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- polypeptides
- peptide
- immunocontraceptive
- immunocontraceptive methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 230000002796 immunocontraceptive effect Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9613705 | 1996-06-29 | ||
GBGB9613705.4A GB9613705D0 (en) | 1996-06-29 | 1996-06-29 | Novel peptides |
PCT/GB1997/001740 WO1998000536A1 (en) | 1996-06-29 | 1997-06-26 | Immunocontraceptive methods and peptide or polypeptides for use in these methods |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3350097A true AU3350097A (en) | 1998-01-21 |
Family
ID=10796114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU33500/97A Abandoned AU3350097A (en) | 1996-06-29 | 1997-06-26 | Immunocontraceptive methods and peptide or polypeptides for use in these methods |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU3350097A (en) |
CA (1) | CA2259237A1 (en) |
GB (1) | GB9613705D0 (en) |
WO (1) | WO1998000536A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1297942A (en) * | 1999-11-30 | 2001-06-06 | 上海博容基因开发有限公司 | Human uterine globin 13 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
RU2010114013A (en) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | APPLICATION OF A NEUROTROPHIC FACTOR FOR CHOLINERGIC RETAIL NEURONS (NFRCN) AND CHORION GONADOTROPINE BETA (109-145) AS A THERAPEUTIC |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266562A (en) * | 1987-11-19 | 1993-11-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anti-inflammatory agents |
-
1996
- 1996-06-29 GB GBGB9613705.4A patent/GB9613705D0/en active Pending
-
1997
- 1997-06-26 AU AU33500/97A patent/AU3350097A/en not_active Abandoned
- 1997-06-26 WO PCT/GB1997/001740 patent/WO1998000536A1/en active Application Filing
- 1997-06-26 CA CA002259237A patent/CA2259237A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998000536A1 (en) | 1998-01-08 |
GB9613705D0 (en) | 1996-08-28 |
CA2259237A1 (en) | 1998-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL128529A0 (en) | Anti-inflammatory peptides and uses thereof | |
AU6241698A (en) | Tace-like and matrilysin-like polypeptides | |
HUP0102900A3 (en) | Improved solid-phase peptide synthesis and agent for use in such synthesis | |
HUP0001020A3 (en) | Stanol composition and the use thereof | |
AU6990796A (en) | Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions | |
HUP9901186A3 (en) | Pharmaceutical composition for immunomodulation based on peptides and adjuvants | |
AU1731997A (en) | Antipathogenic peptides and compositions comprising them | |
ZA9711156B (en) | HVEM polypeptides and uses thereof | |
IL120561A0 (en) | Peptides suitable for use in immunosuppressive therapy | |
GB9705903D0 (en) | VP22 Proteins and uses thereof | |
AU3076599A (en) | Proapoptotic peptides, dependence polypeptides and methods of use | |
AU5355996A (en) | Human chemokine polypeptides | |
EP1015474A4 (en) | Don-1 gene and polypeptides and uses therefor | |
AU3804397A (en) | Hexameric fusion proteins and uses therefor | |
AU4074997A (en) | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | |
AU3305197A (en) | Non-activated receptor complex proteins and uses thereof | |
AUPN024994A0 (en) | Assay and peptides for use therein | |
AU3116697A (en) | Human interleukin-1j and antagonists thereof | |
AU3350097A (en) | Immunocontraceptive methods and peptide or polypeptides for use in these methods | |
AU7786398A (en) | Stabilization of polypeptides for use in immunoassay procedures | |
AU1142397A (en) | Metal-regulated transporters and uses therefor | |
AU4986097A (en) | Thrombin receptor peptides and uses thereof | |
EP1144629A3 (en) | Further pro polypeptides and sequences thereof | |
GB9606272D0 (en) | Gene and peptides | |
AU5480598A (en) | Composite stratified material and its use for coins |